Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CCL22 antagonists(C-C motif chemokine ligand 22 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Follicular Lymphoma | Phase 1 | DK | 12 Aug 2018 | |
Ovarian Cancer | Preclinical | - | - |